ISRCTN57547229已完成未知
Pharmacokinetics and pharmacodynamics of insulin detemir (Levemir®) and insulin glargine (Lantus®) after subcutaneous injection of increasing doses into morbidly obese type 2 diabetic subjects
niversity Hospital Basel (Switzerland)0 个研究点目标入组 12 人开始时间: 2006年5月9日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/30114246 [added 01/02/2019]
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. History of type 2 diabetes mellitus
- •2. Age 18-65 years
- •3. Body mass index >35 kg/m^2
- •4. HbA1c <10%
排除标准
- •1. Any severely active hepatic, cardiovascular, pulmonary, renal, neurological, musculoskeletal, hematological or endocrine disease
- •2. Pregnant or breast feeding women
- •3. Woman of childbearing potential not using a reliable method of birth control such as oral contraceptives or an intrauterine device (IUD)
- •4. Subjects refusing or unable to give written informed consent
研究者
相似试验
已完成
1 期
Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 DiabetesType 2 DiabetesNCT00982254Profil Institut für Stoffwechselforschung GmbH10
已完成
1 期
A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 DiabetesDiabetes Mellitus, Type 2NCT04582448Novo Nordisk A/S25
撤回
1 期
A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection TherapyDiabetes Mellitus, Type 2NCT02623465Eli Lilly and Company
已完成
1 期
A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection TherapyDiabetes Mellitus, Type 2NCT02703337Eli Lilly and Company30
撤回
1 期
A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection TherapyDiabetes Mellitus, Type 1NCT02623452Eli Lilly and Company